Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 7 studies | 25% ± 7% | |
astrocyte | 5 studies | 29% ± 9% | |
glutamatergic neuron | 4 studies | 34% ± 13% | |
oligodendrocyte precursor cell | 4 studies | 25% ± 7% | |
GABAergic neuron | 3 studies | 33% ± 4% | |
ciliated cell | 3 studies | 23% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 36% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1723.40 | 653 / 653 | 99% | 5.89 | 599 / 605 |
brain | 99% | 900.45 | 2626 / 2642 | 100% | 5.62 | 702 / 705 |
prostate | 100% | 1062.25 | 244 / 245 | 98% | 3.27 | 490 / 502 |
breast | 100% | 1217.79 | 459 / 459 | 95% | 3.25 | 1060 / 1118 |
pancreas | 98% | 522.25 | 323 / 328 | 94% | 2.77 | 168 / 178 |
esophagus | 100% | 937.25 | 1440 / 1445 | 93% | 2.87 | 170 / 183 |
ovary | 100% | 1481.76 | 180 / 180 | 92% | 2.59 | 397 / 430 |
lung | 99% | 840.23 | 571 / 578 | 93% | 2.64 | 1076 / 1155 |
kidney | 99% | 789.37 | 88 / 89 | 92% | 3.33 | 832 / 901 |
adrenal gland | 97% | 937.21 | 251 / 258 | 93% | 3.21 | 215 / 230 |
stomach | 99% | 726.80 | 356 / 359 | 83% | 2.05 | 238 / 286 |
intestine | 100% | 1122.47 | 965 / 966 | 81% | 1.88 | 429 / 527 |
uterus | 100% | 1450.09 | 170 / 170 | 79% | 1.91 | 361 / 459 |
bladder | 100% | 1267.57 | 21 / 21 | 79% | 1.84 | 396 / 504 |
skin | 100% | 976.47 | 1800 / 1809 | 73% | 1.70 | 345 / 472 |
liver | 85% | 323.54 | 193 / 226 | 51% | 0.94 | 207 / 406 |
spleen | 100% | 1034.71 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1119.04 | 1332 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 924.11 | 1188 / 1204 | 0% | 0 | 0 / 0 |
muscle | 96% | 570.41 | 769 / 803 | 0% | 0 | 0 / 0 |
heart | 91% | 542.32 | 781 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 2.10 | 24 / 29 |
tonsil | 0% | 0 | 0 / 0 | 78% | 1.86 | 35 / 45 |
eye | 0% | 0 | 0 / 0 | 57% | 1.52 | 46 / 80 |
peripheral blood | 36% | 310.40 | 339 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0071277 | Biological process | cellular response to calcium ion |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0001652 | Cellular component | granular component |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | CARF |
Protein name | Calcium responsive transcription factor Calcium-responsive transcription factor (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein) (Calcium-response factor) (CaRF) (Testis development protein NYD-SP24) |
Synonyms | ALS2CR8 |
Description | FUNCTION: Acts as a transcriptional activator that mediates the calcium- and neuron-selective induction of BDNF exon III transcription. Binds to the consensus calcium-response element CaRE1 5'-CTATTTCGAG-3' sequence. . |
Accessions | ENST00000414490.5 ENST00000427712.5 F6SXV3 ENST00000457031.5 ENST00000414857.5 ENST00000402905.7 [Q8N187-1] ENST00000438828.4 [Q8N187-1] ENST00000444724.5 ENST00000434998.5 [Q8N187-2] C9JL40 ENST00000447539.5 C9JSN4 F8WDW1 C9JN29 ENST00000414439.5 ENST00000443740.5 Q8N187 C9JZ91 ENST00000432024.5 ENST00000445120.5 C9JT99 F8WDH0 C9JCD6 A0A1B0GX63 ENST00000428585.5 [Q8N187-3] F8WC01 ENST00000320443.12 [Q8N187-3] C9JZI6 ENST00000430899.5 C9JBK9 ENST00000422368.5 ENST00000441569.5 C9JI92 ENST00000431787.5 |